Evidence map›Paper›PMID 41652080›Full record

ArticleClinical and experimental nephrology2026

Illness severity modifies the association between sepsis and survival in critically ill patients with acute kidney injury.

Mahnaz Derakhshan, Mory Ghomshei, Hamid Reza Ansarian

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahnaz DerakhshanConovita Technologies Inc., Winnipeg, Canada. derakhshan@conovita.ca.ORCID http://orcid.org/0000-0003-1369-3443
Mory GhomsheiConovita Technologies Inc., Winnipeg, Canada.
Hamid Reza AnsarianConovita Technologies Inc., Winnipeg, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSepsis and acute kidney injury (AKI) are common, often co-occurring ICU syndromes with high mortality. Although illness severity scores such as the Simplified Acute Physiology Score II (SAPS II) are powerful prognostic tools, it is unclear whether baseline illness severity modifies the relationship between sepsis and mortality in AKI. We hypothesized that this association varies across the severity spectrum.

methodsIn a retrospective cohort of 35,926 adults with AKI, we examined the interaction between sepsis (Sepsis-3 criteria) and baseline illness severity (SAPS II) in relation to 30-day survival. We used multivariable logistic regression adjusted for demographics, comorbidities, and organ dysfunction.

resultsA significant interaction between sepsis and illness severity was observed (p < 0.001). At low severity (SAPS II = 20), sepsis was associated with a 4.3 percentage point reduction in 30-day survival, whereas at high severity (SAPS II = 90), it was associated with a 23.6 percentage point increase in survival, representing a net reversal of 27.9 percentage points. This pattern was robust in sensitivity analyses.

conclusionsIn critically ill patients with AKI, the impact of sepsis on survival is strongly modified by baseline illness severity, reversing from harm at low severity to improved survival at high severity. This paradox challenges the assumption of uniform sepsis risk and suggests that, in the sickest patients, sepsis may indicate a state of potentially reversible organ dysfunction. Incorporating illness severity into AKI prognostication may better capture recovery potential, as severity scores alone may underestimate the likelihood of recovery in severe septic AKI.

Indexed as

Acute Kidney InjurySepsisAdultAgedCritical IllnessFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisPrognosisRetrospective StudiesRisk FactorsSeverity of Illness IndexSimplified Acute Physiology ScoreAcute kidney injuryCritical careEffect modificationIllness severitySepsisSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.